Wang J, Sun N C, Weinstein S M, Canalis R
Department of Pathology, Harbor-UCLA Medical Center, University of California Los Angeles, School of Medicine, and the Harbor-UCLA Research and Education Institute, USA.
Arch Pathol Lab Med. 2000 Aug;124(8):1213-6. doi: 10.5858/2000-124-1213-PTCRBC.
T-cell-rich B-cell lymphoma (TCRBCL) is an uncommon and recently recognized variant of B-cell non-Hodgkin lymphoma characterized by a few large neoplastic B cells amid a predominant population of reactive T lymphocytes and variable numbers of histiocytes. Morphologically, TCRBCL resembles a variety of non-Hodgkin lymphomas and Hodgkin disease. Accurate diagnosis and proper treatment are essential to assure a favorable prognosis. To our knowledge, this is the first report of ethmoid sinus presentation of TCRBCL in an Epstein-Barr virus-negative 51-year-old man. Combined chemotherapy and radiotherapy were administered based on the correct diagnosis. The patient has had a complete response with no recurrence during the 5-year follow-up.
富于T细胞的B细胞淋巴瘤(TCRBCL)是一种罕见且最近才被认识的B细胞非霍奇金淋巴瘤变体,其特征是在主要为反应性T淋巴细胞和数量不等的组织细胞群体中存在少数大的肿瘤性B细胞。形态学上,TCRBCL类似于多种非霍奇金淋巴瘤和霍奇金病。准确的诊断和恰当的治疗对于确保良好预后至关重要。据我们所知,这是第一例关于TCRBCL在一名51岁EB病毒阴性男性筛窦表现的报告。基于正确诊断给予了联合化疗和放疗。该患者已完全缓解,在5年随访期间无复发。